BOLD-100
![]() BOLD-100 Chemical Structure | |
给药 | Intravenous |
---|---|
识别 | |
| |
CAS | 197723-00-5 |
PubChem CID | |
DrugBank | |
ChEBI | |
3D | |
| |
|
BOLD-100,
BOLD-100
参考 文献
[编辑]- ^ U.S. National Library of Medicine. (2020). BOLD-100 in combination with FOLFOX for the treatment of advanced solid tumours. https://clinicaltrials.gov/ct2/show/NCT04421820 (页面
存 档备份,存 于互联网档案 馆) - ^ Bold Therapeutics. (2021). Technology. https://www.bold-therapeutics.com/technology (页面
存 档备份,存 于互联网档案 馆) - ^ Vojkovsky, T., Sill, K., Carie, A. (2018). Manufacture of trans-[tetrachlorobis(1H-inadazole)ruthenate(III)] and compositions thereof (U.S. Patent No. 10, 611,787). U.S. Patent and Trademark Office. https://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=2&f=G&l=50&d=PTXT&S1=10,611,787&OS=10,611,787&RS=10,611,787[
失效 連結 ])